Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD
University of Seville
University of Seville
Shanxi Bethune Hospital
Assistance Publique - Hôpitaux de Paris
University of Tennessee
Federal University of Health Science of Porto Alegre
Machaon Biotherapeutics, Inc.
The Affiliated People's Hospital of Ningbo University
Rigshospitalet, Denmark
Zhongnan Hospital
RenJi Hospital
Biocity Biopharmaceutics Co., Ltd.
European Institute of Oncology
Melbourne Health
Istanbul Aydın University
Federal University of Rio Grande do Sul
Massachusetts General Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Baskent University
Nanjing University of Traditional Chinese Medicine
First Affiliated Hospital of Zhejiang University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Children's Cancer Group, China
iCell Gene Therapeutics
iCell Gene Therapeutics
Assistance Publique - Hôpitaux de Paris
Glycostem Therapeutics BV
University of Liege
University of Copenhagen
Institut Cancerologie de l'Ouest
Chinese PLA General Hospital
Hospices Civils de Lyon
Sichuan University
National Research Center for Hematology, Russia
The First Affiliated Hospital of Soochow University
A.O. Ospedale Papa Giovanni XXIII
First Affiliated Hospital of Zhejiang University
Melbourne Health
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
University of Sao Paulo General Hospital
Curon Biopharmaceutical (Australia) Co Pty Ltd
University of Sydney
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Institut Paoli-Calmettes
University Hospital, Clermont-Ferrand
Zhejiang University
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Huazhong University of Science and Technology
Ciusss de L'Est de l'Île de Montréal